milliporesigma videos

  1. Flexible Manufacturing: Better, Faster Virus Production

    The global vaccine market is growing due to population growth, emerging pathogens and pandemics. The increased demand has led to new vaccines, manufacturing facility projects and increasing investments. Using flexible manufacturing strategies can help meet this growing vaccine demand.

  2. Supply Robustness And Control. Stay Ahead.

    Mega-trends are contributing to a boom in the biopharmaceutical industry. Biopharmaceutical manufacturers are accelerating drug development, optimizing productivity and investing in manufacturing capacity globally.  As a leading partner and supplier to the industry, we strengthen our supply chain to support our commitment of on-time delivery reliability and product quality to help you stay ahead.

  3. Take The Right Path Upstream

    Have you considered the impact of your decisions as you are developing upstream? Make the right decisions. Get upstream development right the first time. Learn more.

  4. Focus On Upstream: Maximize Your Molecule

    You are developing a monoclonal antibody and a world of potential is ahead of you. However, your time to realize this potential is limited. You need to act quickly to get your biological drug to market, but have you considered the impact of your decisions as you are developing upstream? Decisions may be difficult to reverse or will require significant backtracking and resources. Get your upstream development right the first time with MilliporeSigma’s upstream ecosystem.

  5. Going Intensified, Connected Or Continuous?

    Hear how an adaptive and evolving platform of proven and novel technologies enables biomanufacturers to successfully accomplish their bioprocessing goals through either intensified, connected or continuous bioprocessing.

  6. Break Down Roadblocks To Clinical Success - Cell Line Development

    Watch this video to learn the important decisions that each biopharma executive must make to break down roadblocks during the critical first step of cell line development and bring their molecule to clinic successfully.

  7. Parvovirus-Retentive Filter Performance And Removal Mechanisms During Process Interruptions

    This presentation describes a case study using Viresolve® Pro membrane filters where virus retention performance is characterized following process interruptions.

  8. Virus Risk Mitigation In The Development Of Biological Medicinal Products: A Global Regulatory Perspective Vaccine Cell Bank And Virus Seed Characterization

    An overview of the regulatory requirements given in the latest guidance documents as well as a description of new technologies for determining the identity of cell substrates and virus seed stocks and detecting adventitious agent contamination.

  9. What is Next Generation Bioprocessing?

    Leaders address how next generation processing will have a significant impact on how therapies are brought to market, delivering them to patients faster and more cost-effectively than ever before.

  10. Supply Chain Excellence

    Watch experts discuss best practices that can help you manage supply chain risks.